| What we checked | What happened | Result |
|---|---|---|
| Google, the release’s own headline | #2, behind a copy on a local TV station’s site | ✓ yes |
| Google, what patients search (“ibogaine treatment Mexico”) | Not in the top 19 | ✕ no |
| Perplexity, asked about the release’s own news | Cited the USA TODAY page as its #1 source | ✓ yes |
| ChatGPT, same question | Used a copy on another site, not USA TODAY | ! via a copy |
| Either engine, “best clinics in Mexico?” | No press release cited | ✕ no |
| Written or checked by a USA TODAY journalist | No. The distributor “does not create, edit, fact-check, or endorse” it | ✕ no |
Paid PR is not earned media. A paid press release puts your own words on a big site for about $150. Earned media is when a reporter, host or expert chooses to talk about you. Both can be useful. Only one is an endorsement. We measured one paid USA TODAY release the day after it went live, so you can see the difference in numbers.
This is the long version, with the full data. The short version is What a $150 USA TODAY Press Release Actually Buys. We’re not telling anyone never to buy a release. We’re showing what it can and can’t do, so nobody pays for the wrong thing.
The answer on one page
XPR Media is a paid press-release pipe. Gannett, now USA TODAY Co., sells space in a USA TODAY press-release section. XPR is its exclusive feed, and resellers sell a spot for $125 to $250.
What paid PR is
- It’s paid. Gannett announced the XPR deal through its Senior Vice President of Content Monetization.
- No journalist writes it. XPR’s Gannett template says USA TODAY news staff “were not involved in the creation of this content.”
- Normal releases get almost no Google traffic. Four of the five older ones we checked got none. About half the section’s traffic goes to seven supplement “reviews” pages.
- It disappears when the client stops paying. XPR’s terms: content is removed from network sites on termination.
What it can and can’t do
- It isn’t useless for AI. By the next day, Perplexity cited the release as its #1 source for a question about the research visit it announced.
- Mostly for questions about the release. On “best ibogaine clinics in Mexico,” neither ChatGPT nor Perplexity cited any press release.
- ChatGPT skips USA TODAY’s copy. It quoted the release from a syndicated copy on an XPR network site. One likely reason: Gannett licenses Perplexity and says it blocks most unlicensed AI bots.
How a “USA TODAY” press release gets made
No USA TODAY journalist writes it. A client pays an agency, the agency pays XPR, and XPR’s feed drops the release into a press-release section Gannett sells, plus up to 1,500 smaller sites.
How XPR got here
- May 31, 2024 XPR buys Frankly’s press-release business from GameSquare for a $700,000 note (SEC 8-K).
- Jun 4, 2025 Gannett makes XPR its exclusive press-release partner across 200+ USA TODAY Network sites.
- Jul 30, 2025 Gannett licenses its content to Perplexity.
- Oct 30, 2025 Gannett’s CEO says it blocks over 99% of unlicensed AI bots, about 70 million from OpenAI in one month.
- Nov 18, 2025 Gannett renames itself USA TODAY Co.
- Oct 5, 2026 The release we tracked goes live.
- Oct 6, 2026 We measure it in Google, Perplexity and ChatGPT.
It’s a commodity: many storefronts sell the same spot
The same USA TODAY placement is on sale from many resellers (we priced five) for $125 to $250. National wires charge $760 to $1,020 per release. Every reseller is one more storefront for the same spot.
What resellers promise
- Reachwire: a “dofollow link” and “As Seen On usage rights.”
- Search Atlas tells buyers to pick “do-follow channels such as USA Today,” yet its help center says any service claiming to make press-release links dofollow “would put your site at risk of a Google manual penalty.”
- Notified, which sells a USA TODAY add-on: it “cannot guarantee … AI citations.”
What USA TODAY won’t take
- “No medical claims: Health, treatment, or medical efficacy claims are not permitted.”
- Distributors also ban “illicit drug promotion (including Cannabis, ketamine, psychedelics, etc.).”
- Likely for that reason, the clinic’s release never says “ibogaine,” the treatment it sells.
How to tell what you’re looking at
| Paid release on USA TODAY | Wire release | Earned story | |
|---|---|---|---|
| Web address | usatoday.com/ | prnewswire.com/ | usatoday.com/ |
| Who wrote it | The company or its agency | The company or its agency | A journalist |
| Who chose to run it | Whoever paid (no fact-check) | Whoever paid the wire | An editor |
| Accurate wording | “Distributed via USA TODAY’s press-release section” | “Distributed via PR Newswire” | “Featured in USA TODAY” |
What one release did by the next day
The release: “University of Ottawa Researchers Spend a Week Inside Cancún’s Transcend Clinic to Study What Makes Its Care Safe,” distributed Oct 5, 2026. By the next day it was indexed, mostly as copies and sidebar links on press-release networks. It reached Google’s results for its own title, but not for what patients search.
- 3 — Full copy: wboc.com, usatoday.com, lincolnjournal.com
- 30 — Sidebar listing: newsnetmedia.com (Portland 21, Myrtle Beach 7, Norfolk 2)
- 10 — Sidebar listing: mykxlg.com
- 6 — Sidebar listing: lifestyle.myeaglecountry.com
- 1 — Sidebar listing: mycarrollcountynews.com
- No copy found on Gannett’s local papers (spot-checked Tennessean, azcentral, Free Press).
Did it reach people looking for a clinic?
| Google search (US, Oct 6) | The release | Who shows up instead |
|---|---|---|
| Its own headline | ✓ #2 | A wboc.com copy is #1; lincolnjournal.com #3 |
| “Transcend Clinic” Cancun | ! #8 | The clinic’s own site #1 and #1 in the map pack; Recovery.com; Instagram; Facebook |
| ibogaine treatment Mexico (350 searches a month) | ✕ not in top 19 | Experience Ibogaine, Recovery.com, AddictionCenter, Casa Santa Isabel, Beond, Ambio |
| ibogaine clinic Cancun | ✕ not in top 20 | Beond #1; the clinic’s own site #3, and #3 in the map pack |
What the release claims vs what a stranger can check
| The release says | Public proof on Oct 6 | Status |
|---|---|---|
| A University of Ottawa team “spent a week on site” | A video on the clinic’s own YouTube channel; one of the researchers lists the clinic on her resources page. No uOttawa news item. | ! partly |
| The clinic “invited the team to research its patient data together” | We found no public research agreement or published findings from this visit. | ✕ not checkable |
| Every patient is screened; the medical director approves or declines each one | Same claim on the clinic’s site. No numbers: how many screened, how many declined. | ! self-reported |
| 24/7 monitoring by emergency, critical-care, cardiology and psychiatry staff | The team page names doctors with license numbers (we did not verify them). The 24/7 claim can’t be checked. | ! staff list only |
| CEO: “Safety claims should be tested, not just stated.” | The release states the claims without a tested number. Publishing those numbers is the fix. | ! the gap |
That’s the point about paid PR in one table. A paid release lets anyone state anything a reseller will accept. Nobody checks it. Readers and AI engines treat it accordingly.
Google: the section feeds supplement ads, not normal releases
USA TODAY’s press-release section gets an estimated 15,000 to 20,000 Google visits a month worldwide, about 0.1% of USA TODAY’s search traffic. About half of it lands on seven supplement “reviews.” A normal release gets close to nothing.
| Top pages in the section (Oct 6) | Visits/mo |
|---|---|
| ProDentim “reviews” (supplement) | 3,370 |
| Bioma “reviews” (supplement) | 2,524 |
| Section index page | 1,244 |
| PhenQ “reviews” (supplement) | 776 |
| ColonBroom GLP-1 “reviews” (supplement) | 536 |
| Ikaria juice “reviews” (supplement) | 461 |
| Roofing storm-repair release | 426 |
The top 10 pages take 61% of the section’s traffic. The seven supplement “reviews” among them take about half.
AI search: Perplexity cites it. ChatGPT doesn’t.
Sellers now pitch “AI visibility.” Here’s the pattern: USA TODAY press releases show up in Perplexity and Google’s AI answers, and in Ahrefs’ data never in ChatGPT or Gemini.
“We are blocking over 99% of AI-verified bots other than Google that try to scrape our content without licensing agreements in place.”Mike Reed, CEO, Gannett (now USA TODAY Co.), Q3 2025 earnings call, Oct 30, 2025. He added that about 70 million of the 75 million bots blocked that September came from OpenAI.
Not all “AI lift” is the same
Echo ! seen in both engines
Ask about the release, get the release back. “What did the researchers find?” Perplexity cited the USA TODAY page first; ChatGPT used a copy on an XPR network site. Low value.Influence ! small
Ask about the business, and the release is one voice of many. “Is this clinic safe?” Perplexity used it as source 18 of 27, and still raised earlier safety concerns.Lift ✕ not seen
Ask a buying question and get named because of the release. “Best ibogaine clinics in Mexico?” Neither engine used it. This is the kind clients pay for.We asked the AI engines. Here’s what came back.
On Oct 6 we asked Perplexity and ChatGPT three questions a patient or a reporter might ask. The release helped on the narrowest question, not on the money question.
| Question | Perplexity (sonar-pro) | ChatGPT model (gpt-4.1 + web search, via API) |
|---|---|---|
| “Is Transcend Clinic in Cancún a safe place for ibogaine treatment?” The question every buyer asks. | ! mixed “Potentially, but not unequivocally” safe. Repeats the clinic’s safety claims. Cites the USA TODAY release as source 18 of 27, and still raises earlier safety concerns. | ✕ leans negative Won’t call it safe. Leans on news coverage, forum posts and the clinic’s own terms. No press release cited. |
| “What are the best ibogaine treatment clinics in Mexico?” The money question. | release absent The clinic is #2 of 8. Sources: PlacidWay ×5, HealingMaps ×3, Recovery.com ×2, news sites. No press release. | release absent The clinic is #5 of 10. 11 of 22 citations come from one directory. No press release. |
| “What did University of Ottawa researchers find at Transcend Clinic?” The release’s own story. | ✓ release used Perplexity restates it. The USA TODAY page is source #1 and the only real source. | ✓ release used, via a copy ChatGPT restates it from a syndicated copy on an XPR network site, not USA TODAY. |
What the engines read before answering the safety question
| Engine | Sources it cited | What it tells you |
|---|---|---|
| ChatGPT 9 sources | The clinic’s own site ×3 (home, reviews, terms) · a directory listing · a New York Times report on clinics abroad · a PubMed study · state legislature testimony · Reddit ×2 | A third of the answer is the clinic’s own site. The rest is the news cycle and forums. |
| Perplexity 27 sources | The clinic’s own site ×9 · national and Spanish-language news about ibogaine in Cancún · Recovery.com ×2 · a directory listing · the USA TODAY release (1 of 27) | The release is one voice in 27. The clinic’s own pages are the biggest lever it controls. |
Where paid distribution can hurt: links and logos
The risk isn’t the release. It’s what gets sold with it: “backlinks” and “As seen in USA TODAY.”
Links
Link spam includes “links with optimized anchor text in articles, guest posts, or press releases distributed on other sites.” It isn’t a violation if the links carry rel=”nofollow” or rel=”sponsored”.Google Search Central spam policies, updated Aug 28, 2026
“We try to ignore links from things like press releases.”John Mueller, Google, 2018 (Search Engine Roundtable)
- XPR’s homepage counts “Backlinks Generated monthly” as a selling point.
- Copies of this release on five “lifestyle.*” sites (four on one IP block) carry a followed link to the clinic’s old domain. Who runs those sites isn’t confirmed.
Logos
Ads that look like content “are deceptive if they mislead consumers into believing they are independent, impartial, or not from the sponsoring advertiser itself.”FTC Enforcement Policy Statement on Deceptively Formatted Advertisements, Dec 2015
Fake news sites used “the names and logos of major media outlets – such as ABC, Fox News, CBS, CNN, USA Today” to sell acai pills.FTC, April 2011 sweep of 10 operators
- One reseller, Reachwire, sells “As Seen On usage rights” with a USA TODAY placement.
- XPR’s Gannett template labels the page as third-party content that news staff “were not involved” in. A logo on a homepage drops that label.
The wording test: same placement, different risk
| Risky claim | Accurate wording | Why |
|---|---|---|
| “Featured in USA TODAY,” or its logo on a homepage | “Press release distributed via USA TODAY’s press-release section” | No journalist chose it. The FTC calls ads that pass as independent deceptive. |
| “Dofollow backlinks from DA80+ sites” | “Links are for visibility, not ranking credit” | Google’s spam policy names press-release links that pass ranking credit. |
| “AI visibility” | “Perplexity and Google’s AI may cite it for questions it answers” | Ahrefs: 0 ChatGPT or Gemini citations to the section. |
| “Reaches 1,500+ news sites” | “Syndicated across a network; most copies are sidebar listings” | 47 of the first 50 Google results for this release’s title were sidebar listings. |
| “University researchers validated our safety” | “Researchers visited; findings not yet published” | USA TODAY bans medical claims. We found no published findings from the visit. |
How we think about paid PR
Paid placement is rented. Earned media is owned. Paid PR has a place; it just isn’t an endorsement. Here’s our own practice, and the test we use.
“We never pay for links and never pay for PR … not this PR pay-for-media, arms-length endorsement strategy. We believe in what’s real.”Dennis Yu, Aug 5, 2026
“When you have the truth and you organize it … AI should be able to multiply that. You don’t need PR, marketing, sales, trickery, and slogans from an advertising agency.”Dennis Yu, Aug 22, 2026
“Instead of PR, which is like trying to twist the news … we’re just going to have the good things stand out. … the truth will stand out.”Dennis Yu, Aug 22, 2026
“If both pages would still exist with no linking benefit at all, it is a relationship. If not, it is a scheme.”Reciprocal Credibility, Aug 7, 2026
Paid release vs our playbook
| Paid release ($125–$250) | Our playbook (truth inventory + Content Factory) | |
|---|---|---|
| Who decides it runs | Anyone who pays | A real third party chose to talk about you, or it’s your own proof, organized |
| How long it lasts | Until the client stops paying | Permanent, and it compounds |
| Links ignored; ranks for its own headline | Builds the entity: Knowledge Graph, schema, Wikidata, Grokipedia | |
| AI answers | Perplexity and Google sometimes; ChatGPT only through copies | Every engine reads earned coverage and clear first-party facts |
| Risk | Logos, “backlinks,” the supplement neighborhood | Low: every claim has a source a stranger can open |
| What the client keeps | Rented pages on someone else’s site | Proof it owns, and outcomes it can measure |
Our “relationship or scheme” test, applied to this case
| The page or link | Exists with no payment or link benefit? | What it is |
|---|---|---|
| The USA TODAY release | No. Someone paid an agency for it. | Paid placement |
| 47 sidebar listings on network sites | No. They distribute releases. | Distribution, not endorsement |
| A researcher lists the clinic on her own resources page | Yes. Her choice, on her site. | Relationship: the best asset here |
What works better: the truth inventory
Here is how the four-stage Content Factory would handle a clinic like this one, instead of another release.
- Fix 10 questions today: 5 about the business and 5 buying questions.
- Ask them every week in ChatGPT, Perplexity, Gemini and Google’s AI. It costs a few cents a question.
- Score each answer: named? cited? which page? positive or negative?
- Report every Friday in a Metrics → Analysis → Action note. How we track AI citations.
- Link the one domain that loads.
- Get written OK from anyone the release quotes or describes.
- No USA TODAY logo. Call it what it is: a distributed press release.
- Links nofollow or sponsored.
- One release per real event, linking to a page with the proof.
A 30-day pilot
Questions people ask
Is paid PR the same as earned media?
No. Paid PR is when you pay to place your own words, like a press release in a news site’s press-release section. Earned media is when a reporter, host or expert chooses to talk about you. Both can be useful, but only earned media is an endorsement.
Is a USA TODAY press release the same as being featured in USA TODAY?
No. A release in USA TODAY’s press-release section is paid placement of your own text, sold through resellers for about $125 to $250. A feature is when USA TODAY’s journalists choose to write about you.
Can a paid press release get you into AI answers?
Sometimes. In our test, Perplexity cited the USA TODAY page as its top source by the next day for a question about the release’s own news. ChatGPT used a copy on another site, and neither engine used any press release for the buying question.
Do press release links help SEO?
Very little. Google says it tries to ignore links from press releases, and its spam policy lists links with optimized anchor text in distributed press releases as link spam unless they carry rel="nofollow" or rel="sponsored".
When is a paid press release worth it?
When you have real news, you word it accurately (“distributed via”), the links are nofollow or sponsored, and you measure the same questions in the same AI engines before and after.
Sources and method
| Fact | Source | Date |
|---|---|---|
| Gannett–XPR exclusive deal, 200+ sites; SVP Content Monetization | Business Wire release | Jun 4, 2025 |
| XPR bought Frankly’s press-release business for a $700,000 note | SEC 8-K, GameSquare Holdings | May 31, 2024 |
| XPR: 1,000+ sites, 150,000+ stories a month; now 1,500+ sites | Business Wire boilerplate; xpr.media home, about, partners and terms pages | Jun 2025; Oct 6, 2026 |
| Reseller prices $125–$250; wire benchmarks | Reachwire, EIN Presswire, PressRelease.com, RedPress, King Newswire; PR Newswire 2021 guide | Oct 6, 2026 |
| USA TODAY content rules (no medical claims, no psychedelics) | Search Atlas help center articles | Sep 30, 2026 |
| Section traffic, top pages, older releases | Ahrefs Site Explorer, usatoday.com/press-release/ | Sep 15–Oct 6, 2026 |
| AI citations by engine | Ahrefs AI-responses index | Oct 6, 2026 |
| Google results for the release and for buyer searches | DataForSEO Google results, US, English | Oct 6, 2026 |
| Live AI answers (3 questions × 2 engines) | DataForSEO LLM responses: Perplexity sonar-pro; ChatGPT gpt-4.1 with web search | Oct 6, 2026 |
| Gannett blocks AI bots; Perplexity license | Gannett Q3 2025 earnings call; Business Wire | Oct 30, 2025; Jul 30, 2025 |
| Share of AI citations from press releases | Muck Rack, “What Is AI Reading?” reports | Jul 2025 – May 2026 |
| Link-spam and site-reputation rules | Google Search Central spam policies | Updated Aug 28, 2026 |
| Disguised ads; “As seen on” logos | FTC policy statement; FTC press release on fake news sites | Dec 2015; Apr 2011 |
| The release’s claims and the public record | The release text as syndicated (wboc.com copy); the clinic’s website; uottawa.ca; the researcher’s website | Oct 5–6, 2026 |
Originally published .

